Longview Partners (Guernsey) LTDLongview Partners (Guernsey) LTD

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings25 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

WEST PHARMACEUTICAL SERVICES

1.3M$329.7M4.7%$267.63-6.48%
3 qtrssince 2025-Q3
Increased
67

THERMO FISHER SCIENTIFIC INC

662,828$325.8M4.6%$525.60-3.33%
10 qtrssince 2023-Q4
Decreased
0

AMERICAN EXPRESS CO

1.1M$325.3M4.6%$88.83+246.52%
26 qtrssince 2019-Q4
Decreased
0

IQVIA HOLDINGS INC

1.9M$323.6M4.6%$130.17+33.64%
25 qtrssince 2020-Q1
Decreased
0

MSCI INC

587,264$316.5M4.5%$559.76-4.40%
4 qtrssince 2025-Q2
Decreased
0

AON PLC

976,263$315.1M4.5%$193.32+66.52%
24 qtrssince 2020-Q2
Decreased
0

BOOKING HOLDINGS INC

74,430$313.4M4.4%$65.44+156.73%
15 qtrssince 2022-Q3
Decreased
0

VISA INC-CLASS A SHARES

1M$313.4M4.4%$220.05+36.81%
13 qtrssince 2023-Q1
Decreased
0

MOODY'S CORP

709,634$309.6M4.4%$268.25+61.90%
17 qtrssince 2022-Q1
Decreased
0

BECTON DICKINSON AND CO

1.9M$304.9M4.3%$166.84-6.42%
21 qtrssince 2021-Q1
Decreased
0

UNITEDHEALTH GROUP INC

1.1M$303.5M4.3%$293.10-1.33%
29 qtrssince 2019-Q1
Decreased
0

MICROSOFT CORP

818,886$303.1M4.3%$254.38+58.79%
16 qtrssince 2022-Q2
Decreased
0

ALPHABET INC-CL A

1M$301.4M4.3%$94.13+222.52%
24 qtrssince 2020-Q2
Decreased
0

CME GROUP INC

1M$300.4M4.3%$275.83+17.87%
2 qtrssince 2025-Q4
Decreased
0

TEXAS INSTRUMENTS INC

1.5M$294.8M4.2%$192.170.00%
1 qtr
New
87
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

849,740$287.2M4.1%$353.130.00%
1 qtr
New
86

SALESFORCE.COM INC

1.5M$282.5M4.0%$267.34-26.67%
5 qtrssince 2025-Q1
Decreased
0

SYSCO CORP

3.9M$279.2M4.0%$57.01+54.38%
27 qtrssince 2019-Q3
Decreased
0

CDW CORP/DE

2.3M$278.6M3.9%$173.94-27.98%
18 qtrssince 2021-Q4
Decreased
0

COOPER COS INC/THE

3.8M$273.3M3.9%$83.370.00%
1 qtr
New
86
$7.1B
AUM
25
Positions
Q1 2026
Filing
Rating · 4.0
Quarterly Portfolio Change
-8%Q4'24$13.4B-7%Q1'25$12.4B-7%Q2'25$11.6B-18%Q3'25$9.6B+0%Q4'25$9.6B-26%Q1'26$7.1B
Activity profile
$ moved · Q1'26
New20%Increased0%Decreased70%Exited10%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.6 years
<1Q12%1-4Q12%1-2Y4%2Y+72%

Longview Partners (Guernsey) LTD manages $7.1B across 25 positions as of Q1 2026. Top holdings: WST (4.7%), TMO (4.6%), AXP (4.6%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 4/5.0.

Q1 2026 Summary

Added 3 new positions, exited 1, increased 1, trimmed 21. Top move: TXN (NEW, conviction 87). Portfolio: $7.1B across 25 positions.

Top holdings by portfolio weight

Total AUM$7B
WST4.67%
TMO4.62%
AXP4.61%
IQV4.58%
MSCI4.48%
AON4.46%
BKNG4.44%
V4.44%
MCO4.39%
BDX4.32%
Other4.30%

Portfolio allocation by GICS sector

Sectors7
Financial Services30.67%
Healthcare26.36%
Technology24.21%
Consumer Cyclical8.23%
Communication Services4.27%
Consumer Defensive3.96%
Unknown2.29%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services, Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record75
Conviction44
Concentration75
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used